By REUTERSAPRIL 21, 2015
DuPont’s weak quarterly sales and reduced annual profit forecast is expected to provide fresh ammunition to the activist investor Nelson Peltz in his campaign to split up the chemical maker. Mr. Peltz’s hedge fund, Trian Fund Management, is DuPont’s fifth-largest shareholder with a 2.7 percent stake. It started a proxy battle in January for four board seats, including one for Mr. Peltz. DuPont said on Tuesday that it expected full-year operating earnings to be at the low end of its previous forecast as the strong dollar hurts overseas revenue. Trian did not immediately respond to requests for comment. Sales fell 9 percent, the biggest decline in five quarters.A version of this brief appears in print on April 22, 2015, on Page B2 of the New York edition with the headline: Dupont’s Underperformance Could Spur Activist Investor.  Order Reprints| Today's Paper|Subscribe

We’re interested in your feedback on this page. Tell us what you think.